Systemic lupus erythematosus: Emerging concepts. Part 2: Dermatologic and joint disease, the antiphospholipid antibody syndrome, pregnancy and hormonal therapy, morbidity and mortality, and pathogenesis Review uri icon

Overview

MeSH Major

  • Lupus Erythematosus, Systemic

abstract

  • The optimal treatment for dermatologic disease and the antiphospholipid antibody syndrome in patients with systemic lupus erythematosus remains unknown. Although mortality has decreased substantially, the morbidity related to the disease itself and to complications of therapy is still considerable. More studies are needed to further elucidate the effects of pregnancy on this condition and the pathogenetic mechanisms responsible for the development of this disease.

publication date

  • January 1995

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 7762914

Additional Document Info

start page

  • 42

end page

  • 53

volume

  • 123

number

  • 1